Your Current Location： Brand Column >文献速递

石教授讲妇产科故事

国际新镜界

Rare but vigilant
Vaginal trial vs. cesarean section at 22-25 weeks showed no difference in fetal outcomes and vs. maternal risk
A new breakthrough in cesarean section suturing! AJOG: "Suture-free intima " reduces the risk of uterine scarring and diverticula by 47%, building a strong line of defense for pregnancy safety
After first-line treatment for ovarian cancer, how to choose maintenance treatment? PARP inhibitors monotherapy or combination?
BJOG: Don't hit the line! Primiparous women (BMI<18.5) weight management during pregnancy, keep an eye on these 3 factors to prevent perineal damage!
CA: Say goodbye to "one-size-fits-all"! Personalized medicine for high-grade serous ovarian cancer: from molecular mechanisms to precise protocols
AJOG: How to choose oral antihypertensive drugs during pregnancy? The latest comparison of the efficacy and safety of the three commonly used drugs
Levonorgestrel intrauterine device and breast cancer risk
JAMA study丨Discontinuation of GLP-1 receptor agonists during pregnancy is associated with adverse pregnancy outcomes, and the risk of weight gain increases significantly
BMJ Study丨Why can't you stop gestational diabetes after desperately dieting before pregnancy?

上一页 1 2 下一页

共 2 页